This improvement occurs through multiple mechanisms: reduced aromatase activity as fat mass decreases, improved insulin sensitivity, decreased inflammatory cytokines, and restoration of normal hypothalamic-pituitary function
CJC-1295 No DAC Mod GRF 1-29 produces a sharp, pulsatile GH release that mirrors how the body actually secretes growth hormone
But experts agree if you're seeing results at the starter dose, you don't have to change
All participants had a BMI 27 kg/m, established cardiovascular disease (prior MI, stroke, or peripheral artery disease), but no diabetes, making this the largest trial of a GLP-1RA in a non-diabetic, high-risk cardiovascular cohort
He says the study highlights the need for openness and transparency in the investigations that lead to research being retracted